Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 257

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 257
---
 Effects that have occurred through the date of determination of the occurrence of a material adverse effect, has had, or is reasonably likely to have, a material adverse effect on the business, assets and liabilities, financial condition or results of operations of Channel and its subsidiaries, taken as a whole; provided, however, that no Effect, to the extent resulting from or arising out of any of the following, alone or in combination, will be deemed to be a material adverse effect with respect to Channel or be taken into account for purposes of determining whether a material adverse effect with respect to Channel has occurred or is reasonably likely to occur:

| • | changes after the date of the Merger Agreement in prevailing economic or market conditions in the United States or any other jurisdiction (except to the extent those changes have a disproportionate effect on Channel and its subsidiaries relative to the other participants in their industries); |

| • | changes or events after the date of the Merger Agreement affecting the industry or industries in which Channel and its subsidiaries operate generally (except to the extent those changes or events have a disproportionate effect on Channel and its subsidiaries relative to the other participants in the industry or industries in which Channel and its subsidiaries operate); |

| • | changes after the date of the Merger Agreement in GAAP or requirements or the interpretation thereof (except to the extent those changes have a disproportionate effect on Channel and its subsidiaries relative to the other participants in the industry or industries in which Channel and its subsidiaries operate); |

| • | changes after the date of the Merger Agreement in laws, rules or regulations of general applicability or interpretations thereof by any governmental entity (except to the extent those changes have a disproportionate effect on Channel and its subsidiaries relative to the other participants in the industry or industries in which Channel and its subsidiaries operate); |

| • | any natural disaster, epidemic, pandemic or other disease outbreak or any outbreak of major hostilities or any act of terrorism (except to the extent those changes or events have a disproportionate effect on Channel and its subsidiaries relative to the other participants in the industry or industries in which Channel and its subsidiaries operate); |

| • | a change in the public trading price of Channel common stock or the implications thereof (it being understood that any Effect causing or giving rise to any such change shall be taken into account for purposes of determining whether a material adverse effect has occurred or is reasonably likely to occur); |

| • | the execution, delivery, announcement or performance of the obligations under the Merger Agreement or the announcement, pendency or anticipated consummation of the